Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity
Authors:
- Ana Vitoria Barban MarguttiAMAna Vitoria Barban Margutti
- Wilson Araújo SilvaWSWilson Araújo Silva
- Daniel Fantozzi GarciaDGDaniel Fantozzi Garcia
- Greice Andreotti de MolfettaGMGreice Andreotti de Molfetta
- Adriana Aparecida MarquesAMAdriana Aparecida Marques
- Tatiana AmorimTATatiana Amorim
- Vânia Mesquita Gadelha PrazeresVPVânia Mesquita Gadelha Prazeres
- Raquel Tavares Boy da SilvaRSRaquel Tavares Boy da Silva
- Irene Kazue MiuraIMIrene Kazue Miura
- João Seda NetoJNJoão Seda Neto
- Emerson de Santana SantosESEmerson de Santana Santos
- Mara Lúcia Schmitz Ferreira SantosMSMara Lúcia Schmitz Ferreira Santos
Open Access
- 1 November 2020
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 15 (1) , 1-11
Abstract
Background: Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disease caused by deficient activity of the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by BCKDHA, BCKDHB, DBT, and DLD genes. MSUD is predominantly caused by Variants in BCKDHA, BCKDHB, and DBT genes encoding the E1α, E1β, and E2 subunits of BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD by identifying the point variants in BCKDHA, BCKDHB, and DBT genes in a cohort of Brazilian MSUD patients and to describe their phenotypic heterogeneity. It is a descriptive cross-sectional study with 21 MSUD patients involving molecular genotyping by Sanger sequencing. Results: Eight new variants predicted as pathogenic were found between 30 variants (damaging and non-damaging) identified in the 21 patients analyzed: one in the BCKDHA gene (p.Tyr120Ter); five in the BCKDHB gene (p.Gly131Val, p.Glu146Glnfs * 13, p.Phe149Cysfs * 9, p.Cys207Phe, and p.Lys211Asn); and two in the DBT gene (p.Glu148Ter and p.Glu417Val). Seventeen pathogenic variants were previously described and five variants showed no pathogenicity according to in silico analysis. Conclusion: Given that most of the patients received late diagnoses, the study results do not allow us to state that the molecular features of MSUD variant phenotypes are predictive of clinical severity.Keywords
All Related Versions
Funding Information
- Nucleus of Research Support
- Center for Integrative Systems Biology of University of São Paulo- Brazil
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 35 references indexed in Scilit:
- Liver Transplantation for Classical Maple Syrup Urine Disease: Long-Term Follow-Up in 37 Patients and Comparative United Network for Organ Sharing ExperienceThe Journal of Pediatrics, 2012
- Incidence of maple syrup urine disease in PortugalMolecular Genetics and Metabolism, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Automated inference of molecular mechanisms of disease from amino acid substitutionsBioinformatics, 2009
- Molecular and structural analyses of maple syrup urine disease and identification of a founder mutation in a Portuguese Gypsy communityMolecular Genetics and Metabolism, 2008
- Description of the mutations in 15 subjects with variant forms of maple syrup urine diseaseJournal of Inherited Metabolic Disease, 2007
- Mutational spectrum of maple syrup urine disease in SpainHuman Mutation, 2006
- Elective Liver Transplantation for the Treatment of Classical Maple Syrup Urine DiseaseAmerican Journal of Transplantation, 2006
- Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine diseaseHuman Mutation, 2003
- Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain α-keto acid dehydrogenase complexJournal of Human Genetics, 1998